On the Role of Mining Exposure in Epigenetic Effects in Parkinson’s Disease
- 29 April 2017
- journal article
- research article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 32 (2) , 172-174
Abstract
To explore the possible influence of heavy metal mining on incidence of Parkinson’s disease (PD), global DNA methylation was assessed in blood samples from a population of PD patients (n = 45) and control subjects (n = 52) in Antofagasta neighborhood, a Chilean city built for exclusive use of mining companies. Comparisons were made with PD subjects (n = 52) and control subjects (n = 59) from Santiago Chile, a city having little association with mining. All subjects were assessed by two neurologists and PD diagnosis was based on UK Parkinson’s Disease Society Brain Bank Clinical Diagnostic Criteria. From blood samples obtained from each individual, a decrease in global DNA methylation was observed in PD patients either exposed (49% of control, P < 0.001) or not exposed (47% of control, P < 0.001) to mining activity. Although there was no difference in levels of DNA methylation between PD patients from the two cities, there was a lower level of DNA methylation in control subjects from Santiago versus Antofagasta.Keywords
This publication has 10 references indexed in Scilit:
- Parkinson’s disease and occupational exposures: a systematic literature review and meta-analysesScandinavian Journal of Work, Environment & Health, 2017
- Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson’s Disease: Epicenter or Outcome, Yet a Demigod QuestionMolecular Neurobiology, 2016
- DNA methylation in Parkinson's diseaseJournal of Neurochemistry, 2016
- Manganese neurotoxicity: behavioral disorders associated with dysfunctions in the basal ganglia and neurochemical transmissionJournal of Neurochemistry, 2015
- The prevalence of Parkinson's disease: A systematic review and meta‐analysisMovement Disorders, 2014
- Mortalidad por enfermedad de Parkinson en ChileRevista médica de Chile, 2013
- CpG Demethylation Enhances Alpha-Synuclein Expression and Affects the Pathogenesis of Parkinson's DiseasePLOS ONE, 2010
- Methylation Regulates Alpha-Synuclein Expression and Is Decreased in Parkinson's Disease Patients' BrainsJournal of Neuroscience, 2010
- THE PRICE OF DEVELOPMENT IN CHILENeuroReport, 2001
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992